Case Report: Anti-LGI1 encephalitis during FcRn inhibition with efgartigimod for myasthenia gravis: implications for the limitations of IgG recycling blockade
ObjectivesAnti–leucine-rich glioma-inactivated 1 (LGI1) antibody–associated autoimmune encephalitis is a treatable disorder characterized by subacute cognitive impairment. Efgartigimod is a neonatal Fc receptor (FcRn) antagonist that reduces circulating IgG levels. It is approved for the treatment o...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Frontiers Media S.A.
2026-05-01
|
| Serie: | Frontiers in Immunology |
| Ämnen: | |
| Länkar: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1854357/full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|